• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 99008G!
Device Problems Nonstandard Device (1420); Incorrect Or Inadequate Test Results (2456); Low Test Results (2458)
Patient Problems No Consequences Or Impact To Patient (2199); Patient Problem/Medical Problem (2688); No Code Available (3191)
Event Type  malfunction  
Manufacturer Narrative
Investigation conclusion: investigation pending.
 
Event Description
Report received of discrepant inratio value.Event occurred in (b)(6).Patient's therapeutic range not provided.Unknown date inratio inr = 2.3.Fourteen (14) days after the inratio inr result, the patient was hospitalized due to an acute gout attack.While in the hospital the following result was obtained: inr via lab = 6.0.Dates of hospitalization and treatment administered is unknown.No additional information provided.
 
Manufacturer Narrative
Investigation/conclusion: it is indicated that the product is not returning for evaluation.Therefore, a review of the entire in-house testing history of the lot was performed.In-house testing on the reported strip lot met release criteria.The product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.Improper techniques and a user issue were identified in the complaint.These could not be ruled out as a cause of the unexpected results.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Manufacturer Narrative
Investigation/conclusion.The meter associated with the complaint was returned for investigation.In-house testing on the returned meter using retained test strips met accuracy criteria.The customer's complaint was not replicated.The returned meter passed functional and thermistor testing requirements during in-house investigation.The system performed within expectations.A statistical analysis of the impedance curve generated using the customer's reported inratio inr result determined that the curve did not exhibit a weak or abnormal slope.A review of the entire in-house testing history of the lot was performed.In-house testing on the reported strip lot met release criteria.The product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.The customer was identified as having a condition that may impact the performance of the assay, having a user issue, and was using improper technique.Patient sample interference could not be ruled out as a cause for the unexpected result.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Manufacturer Narrative
Investigation/conclusion: the meter associated with the complaint was returned for investigation.In-house testing on the returned meter using retained test strips met accuracy criteria.The customer's complaint was not replicated.The returned meter passed functional and thermistor testing requirements during in-house investigation.The system performed within expectations.The customer did not provide a date of occurrence which prevented the identification of the discrepant result in the meter memory.Statistical analysis of the impedance curve of a possible inr result was performed and determined that the curve did not exhibit a weak or abnormal slope.It is unknown if this is the actual impedance curve resulting in the reported discrepant result.A review of the entire in-house testing history of the lot was performed.In-house testing on the reported strip lot met release criteria.The product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.The customer was identified as having a condition that may impact the performance of the assay, having a user issue, and was using improper technique.Patient sample interference could not be ruled out as a cause for the unexpected result.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5929360
MDR Text Key54528913
Report Number2027969-2016-00604
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K110212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Reporter Occupation Attorney
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 08/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number99008G!
Device Lot NumberK384108
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/28/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/09/2016
Initial Date FDA Received09/06/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received11/14/2016
01/05/2017
01/24/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberZ-2354-2016- Z-2362-2016
Patient Sequence Number1
Treatment
ASS; BISOPROLOL; CANDESARTAN; INRATIO MONITOR SERIAL #(B)(4); PANTOPRAZOL; SIMVASTATIN; TRIAMTEREN; UNSPECIFIED ASTHMA MEDICATION
-
-